Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sanofi
Sanofi
Sanofi Q4 earnings hit by weak dollar, generic competition
Reuters
Thu, 02/1/24 - 11:25 am
Sanofi
earnings
Dupixent
Aubagio
Sanofi pays Synthekine $40M to join preclinical push against vexing inflammatory target
Fierce Biotech
Mon, 01/29/24 - 11:07 am
Sanofi
Synthekine
cytokines
inflammatory diseases
Sanofi, Regeneron Win Dupixent Label Expansion to Treat Eosinophilic Esophagitis
BioSpace
Fri, 01/26/24 - 11:19 am
Regeneron
Sanofi
Dupixent
eosinic esophagitis
pediatric
FDA
Sanofi to buy U.S. drugs project INBRX-101 for about $2.2 billion
Reuters
Tue, 01/23/24 - 10:48 am
Sanofi
M&A
Inhibrx
6 Neuro Data Readouts to Watch in the First Half of 2024
BioSpace
Mon, 01/22/24 - 11:53 am
neurodegenerative disease
clinical trials
ALS
major depressive disorder
Huntington's disease
Sanofi
Denali Therapeutics
Intra-Cellular Therapies
lumateperone
Annexon Biosciences
Guillain-Barré Syndrome
ANX005
Wave Life Sciences
Praxis Precision Medicines
FDA updates Sanofi’s Dupixent label for atopic dermatitis
Pharmaceutical Business Review
Wed, 01/17/24 - 09:26 am
Sanofi
Dupixent
FDA
atopic dermatitis
Drugs group Sanofi makes Olympic jump in rebrand bid
Reuters
Wed, 01/10/24 - 09:32 am
Sanofi
Olympics
rebranding
10 clinical trials to watch in the first half of 2024
BioPharma Dive
Wed, 01/3/24 - 05:08 pm
clinical trials
Beam Therapeutics
Moderna Therapeutics
Pfizer
Sanofi
Gilead Sciences
JNJ
Amylx
Roche
Alnylam Pharmaceuticals
Vertex Pharmaceuticals
AZ, Sanofi’s Beyfortus cleared in China for RSV prevention
Pharmaphorum
Tue, 01/2/24 - 10:09 am
AstraZeneca
Sanofi
Beyfortus
RSV
vaccines
China
Drugmakers set to raise US prices on at least 500 drugs in January
Reuters
Tue, 01/2/24 - 09:59 am
drug pricing
Pfizer
Sanofi
Takeda
Sanofi’s oncology strategy suffers another blow as ADC scrapped over phase 3 lung cancer fail
Fierce Biotech
Thu, 12/21/23 - 09:40 am
Sanofi
antibody-drug conjugate
lung cancer
clinical trials
tusamitamab ravtansine
Immunogen
Failed Illumina and Sanofi Deals Shine Light on FTC Antitrust Crackdown
BioSpace
Wed, 12/20/23 - 06:41 pm
Illumina
Grail
Sanofi
Maze Therapeutics
FTC
M&A
antitrust
AstraZeneca, Sanofi to supply 230,000 more RSV infant shots to US market
Reuters
Thu, 12/14/23 - 10:48 pm
RSV
vaccines
Sanofi
AstraZeneca
Sanofi pharmaceutical plant found to have leaked neurotoxin in south-western France
RFI
Wed, 12/13/23 - 10:12 pm
Sanofi
France
drug manufacturing
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
Fierce Pharma
Wed, 12/13/23 - 09:45 am
ASH 2023
JNJ
Sanofi
Darzalex
Sarclisa
Multiple Myeloma
FTC, in unusual move, leads Sanofi to terminate a drug research deal
BioPharma Dive
Tue, 12/12/23 - 10:43 pm
FTC
Sanofi
R&D
Maze Therapeutics
Kymera’s protein degrader starts Phase II trial in atopic dermatitis
Clinical Trials Arena
Fri, 12/8/23 - 11:05 am
Kymera
Sanofi
protein degradation
clinical trials
atopic dermatitis
KT-474
Sanofi’s Phase III multiple myeloma trial meets primary goal
Clinical Trials Arena
Fri, 12/8/23 - 11:02 am
Sanofi
cliincal trials
Sarclisa
Multiple Myeloma
monoclonal antibodies
Dupixent for cancer? Researchers test blockbuster med as an immunotherapy-booster
Fierce Biotech
Thu, 12/7/23 - 11:13 pm
Regeneron
Sanofi
Dupixent
cancer
lung cancer
Sanofi CEO: Drugmaker has stocked pipeline but must win over investors
Medical Marketing and Media
Thu, 12/7/23 - 11:10 pm
Sanofi
Paul Hudson
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »